637 related articles for article (PubMed ID: 14981298)
1. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption.
Moriyama T; Kishimoto K; Nagai K; Urade R; Ogawa T; Utsumi S; Maruyama N; Maebuchi M
Biosci Biotechnol Biochem; 2004 Feb; 68(2):352-9. PubMed ID: 14981298
[TBL] [Abstract][Full Text] [Related]
2. Effects of soybean beta-conglycinin on hepatic lipid metabolism and fecal lipid excretion in normal adult rats.
Fukui K; Kojima M; Tachibana N; Kohno M; Takamatsu K; Hirotsuka M; Kito M
Biosci Biotechnol Biochem; 2004 May; 68(5):1153-5. PubMed ID: 15170126
[TBL] [Abstract][Full Text] [Related]
3. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein.
Yamazaki T; Kishimoto K; Miura S; Ezaki O
J Nutr Biochem; 2012 Feb; 23(2):123-32. PubMed ID: 21447441
[TBL] [Abstract][Full Text] [Related]
4. Beta-conglycinin lowers very-low-density lipoprotein-triglyceride levels by increasing adiponectin and insulin sensitivity in rats.
Tachibana N; Iwaoka Y; Hirotsuka M; Horio F; Kohno M
Biosci Biotechnol Biochem; 2010; 74(6):1250-5. PubMed ID: 20530915
[TBL] [Abstract][Full Text] [Related]
5. Soya protein β-conglycinin ameliorates fatty liver and obesity in diet-induced obese mice through the down-regulation of PPARγ.
Li D; Ikaga R; Yamazaki T
Br J Nutr; 2018 Jun; 119(11):1220-1232. PubMed ID: 29770757
[TBL] [Abstract][Full Text] [Related]
6. Dietary β-Conglycinin Modulates Insulin Sensitivity, Body Fat Mass, and Lipid Metabolism in Obese Otsuka Long-Evans Tokushima Fatty (OLETF) Rats.
Kawabeta K; Hase-Tamaru S; Yuasa M; Suruga K; Sugano M; Koba K
J Oleo Sci; 2019 Apr; 68(4):339-350. PubMed ID: 30867392
[TBL] [Abstract][Full Text] [Related]
7. Reduction by phytate-reduced soybean beta-conglycinin of plasma triglyceride level of young and adult rats.
Aoyama T; Kohno M; Saito T; Fukui K; Takamatsu K; Yamamoto T; Hashimoto Y; Hirotsuka M; Kito M
Biosci Biotechnol Biochem; 2001 May; 65(5):1071-5. PubMed ID: 11440119
[TBL] [Abstract][Full Text] [Related]
8. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats.
Tachibana N; Yamashita Y; Nagata M; Wanezaki S; Ashida H; Horio F; Kohno M
Nutr Res; 2014 Feb; 34(2):160-7. PubMed ID: 24461318
[TBL] [Abstract][Full Text] [Related]
9. The α' subunit of β-conglycinin and various glycinin subunits of soy are not required to modulate hepatic lipid metabolism in rats.
Chatterjee C; Liu J; Wood C; Gagnon C; Cober ER; Frégeau-Reid JA; Gleddie S; Xiao CW
Eur J Nutr; 2018 Apr; 57(3):1157-1168. PubMed ID: 28324208
[TBL] [Abstract][Full Text] [Related]
10. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
11. Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease.
Wanezaki S; Tachibana N; Nagata M; Saito S; Nagao K; Yanagita T; Kohno M
Obes Res Clin Pract; 2015; 9(2):168-74. PubMed ID: 25890430
[TBL] [Abstract][Full Text] [Related]
12. Soy β-conglycinin retards progression of diabetic nephropathy via modulating the insulin sensitivity and angiotensin-converting enzyme activity in rats fed with high salt diet.
Yeh WJ; Yang HY; Chen JR
Food Funct; 2014 Nov; 5(11):2898-904. PubMed ID: 25205218
[TBL] [Abstract][Full Text] [Related]
13. Soybean β-conglycinin improves carbohydrate and lipid metabolism in Wistar rats.
Inoue N; Fujiwara Y; Kato M; Funayama A; Ogawa N; Tachibana N; Kohno M; Ikeda I
Biosci Biotechnol Biochem; 2015; 79(9):1528-34. PubMed ID: 25913002
[TBL] [Abstract][Full Text] [Related]
14. Improvement of Triglyceride Levels through the Intake of Enriched-β-Conglycinin Soybean (Nanahomare) Revealed in a Randomized, Double-Blind, Placebo-Controlled Study.
Nishimura M; Ohkawara T; Sato Y; Satoh H; Takahashi Y; Hajika M; Nishihira J
Nutrients; 2016 Aug; 8(8):. PubMed ID: 27529274
[TBL] [Abstract][Full Text] [Related]
15. Soy β-conglycinin (7S globulin) reduces plasma and liver cholesterol in rats fed hypercholesterolemic diet.
Ferreira Ede S; Silva MA; Demonte A; Neves VA
J Med Food; 2011; 14(1-2):94-100. PubMed ID: 21138348
[TBL] [Abstract][Full Text] [Related]
16. Dietary β-conglycinin prevents acute ethanol-induced fatty liver in mice.
Ikaga R; Li D; Yamazaki T
Biochem Biophys Res Commun; 2017 Nov; 493(1):542-547. PubMed ID: 28867186
[TBL] [Abstract][Full Text] [Related]
17. Enzymatically synthesized glycogen reduces lipid accumulation in diet-induced obese rats.
Furuyashiki T; Ogawa R; Nakayama Y; Honda K; Kamisoyama H; Takata H; Yasuda M; Kuriki T; Ashida H
Nutr Res; 2013 Sep; 33(9):743-52. PubMed ID: 24034574
[TBL] [Abstract][Full Text] [Related]
18. The α' subunit of β-conglycinin and the A1-5 subunits of glycinin are not essential for many hypolipidemic actions of dietary soy proteins in rats.
Chen Q; Wood C; Gagnon C; Cober ER; Frégeau-Reid JA; Gleddie S; Xiao CW
Eur J Nutr; 2014 Aug; 53(5):1195-207. PubMed ID: 24276222
[TBL] [Abstract][Full Text] [Related]
19. Dietary soy beta-conglycinin (7S globulin) inhibits atherosclerosis in mice.
Adams MR; Golden DL; Franke AA; Potter SM; Smith HS; Anthony MS
J Nutr; 2004 Mar; 134(3):511-6. PubMed ID: 14988439
[TBL] [Abstract][Full Text] [Related]
20. Beta-conglycinin embeds active peptides that inhibit lipid accumulation in 3T3-L1 adipocytes in vitro.
Martinez-Villaluenga C; Bringe NA; Berhow MA; Gonzalez de Mejia E
J Agric Food Chem; 2008 Nov; 56(22):10533-43. PubMed ID: 18947234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
